AGX
Argan, Inc.
AGX has the edge over BA overall, supported by stronger modeled upside and stronger fundamentals.
BA
The Boeing Company
BA's outlook is improving, though it still trails on the overall score.
AGX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
AGX's revenue, profitability, cash flow and balance sheet are all currently strong.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
AGX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $215 | -32% |
| Forward | 22x | $315 | — |
| Current | 25x | $315 | — |
| Fair | 26x | $326 | +3.5% |
| Expensive | 43x | $546 | +73% |
Historical ranges are pointers, not guarantees.
AGX's PE is in its fair range at 25x. If earnings grow as analysts expect, today's price would be 22x next year's earnings.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over AGX in the historical PE scenario, which offers more potential upside but is not a forecast.
AGX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for AGX, with profitability improving. However, they disagree widely on these estimates.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
AGX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.39 | +14% |
| Q3 2026 | $12.64 | +51% |
| Q2 2026 | $11.38 | +59% |
| Q1 2026 | $9.74 | +58% |
| Q4 2025 | $8.53 | +78% |
| Q3 2025 | $8.36 | +163% |
| Q2 2025 | $7.17 | +155% |
| Q1 2025 | $6.15 | +157% |
| Q4 2024 | $4.78 | +94% |
AGX has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
AGX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $384M | +62% |
| Q2 2026 | $291M | +50% |
| Q1 2026 | $262.1M | +13% |
| Q4 2025 | $251.2M | -2.3% |
| Q3 2025 | $237.7M | +4.7% |
| Q2 2025 | $193.7M | +23% |
| Q1 2025 | $232.5M | +41% |
| Q4 2024 | $257M | +57% |
AGX has the edge over BA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +2.1 points |
| Q2 2026 | 16% | +3 points |
| Q1 2026 | 18% | +4.1 points |
| Q4 2025 | 13% | +1.2 points |
| Q3 2025 | 13% | +4.4 points |
| Q2 2025 | 13% | +8.4 points |
| Q1 2025 | 14% | +6.9 points |
| Q4 2024 | 12% | +7 points |
AGX has the edge over BA on profitability, with a higher operating margin.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
AGX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $91.7M | +179% |
| Q2 2026 | $111M | +218% |
| Q1 2026 | $171.1M | +296% |
| Q4 2025 | $171.9M | +488% |
| Q3 2025 | $32.9M | -54% |
| Q2 2025 | $34.9M | +101% |
| Q1 2025 | $43.3M | +80% |
| Q4 2024 | $29.2M | -48% |
AGX generated $546M in free cash flow over the past year, about four times what it generated the year before.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over AGX on cash flow, with more consistent year-over-year improvement.
AGX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -33K shares |
| 1 year | +0.2% | +33K shares |
| 3 years | +4.6% | +622K shares |
| 5 years | -11% | -1.8M shares |
| Available history | -9.4% | -1.5M shares |
AGX has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.7M |
| Q2 2026 | $3M |
| Q1 2026 | $2.8M |
| Q4 2025 | — |
| Q3 2025 | $199,000 |
| Q2 2025 | $6.8M |
| Q1 2025 | $878,000 |
| Q4 2024 | $459,000 |
AGX spent $12M buying back its own shares over the past year, up 49% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
AGX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.0x | Net Cash |
| Q2 2026 | -2.3x | Net Cash |
| Q1 2026 | -2.5x | Net Cash |
| Q4 2025 | -2.5x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -2.5x | Net Cash |
AGX has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
AGX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.3 | Neutral |
| Stochastic | 10.8 | Oversold |
AGX's weekly RSI is 35 (neutral) and its Stochastic is 11 (oversold).
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
AGX PE vs Industrials Sector
| Metric | AGX | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 24x | 3.7% above |
| PE % | 46 | 58 | 12 pts below |
AGX is trading at 25x earnings, in line with the Industrials sector's median of 24x.
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over AGX on valuation relative to its sector.
AGX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $344.3 | 8.4% below |
| 20 week MA | $454.9 | 31% below |
| 50 week MA | $487.6 | 35% below |
| 100 week MA | $346.8 | 9.1% below |
| 200 week MA | $204.0 | 55% above |
AGX has the edge over BA on trend strength, trading above more of its moving averages.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
AGX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $39.7 | $44.2 | +11% |
| 2021 | $44.2 | $38.2 | -14% |
| 2022 | $38.2 | $36.4 | -4.6% |
| 2023 | $36.4 | $46.8 | +28% |
| 2024 | $46.8 | $143.0 | +206% |
| 2025 | $143.0 | $325.1 | +127% |
| 2026 YTD | $325.1 | $315.3 | -3% |
AGX has the edge over BA on returns for 2026, with the stronger performance.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.